Educational Programs

Disease Overview of Nonalcoholic Steatohepatitis (NASH): The Active, Progressive Form of Nonalcoholic Fatty Liver Disease (NAFLD)

speaker_photo
Keith Miller, PhD

speaker_photo
Christina Hanson, MS, FNP

speaker_photo
Ann Moore, FNP-C

Identifying, Managing, and Treating Patients With NASH and Significant Fibrosis - Current Practice and Future Perspectives
(as presented at EASL 2022)

speaker_photo
Prof Quentin M. Anstee

speaker_photo
Jörn M. Schattenberg, MD

speaker_photo
Stephen A. Harrison, MD, FACP, FAASLD

speaker_photo speaker_photo speaker_photo Q&A Prof Quentin M. Anstee
Jörn M. Schattenberg, MD
Stephen A. Harrison, MD, FACP, FAASLD

Emerging Concepts in Non-Alcoholic Steatohepatitis (NASH): Disease Education Program
(as presented at CLDF 2022)

speaker_photo Mazen Noureddin, MD, MHSc

speaker_photo Marcelo Kugelmas, MD, FAASLD, FACP

speaker_photo speaker_photo Q&A Mazen Noureddin, MD, MHSc
Marcelo Kugelmas, MD, FAASLD, FACP

Patient Video Series in Partnership with the Fatty Liver Foundation (3 Parts)

speaker_photo Scott L. Friedman
MD

speaker_photo Wayne Eskridge

Part I -
Fatty Liver Foundation Development
Wayne Eskridge tells his personal journey as a patient with NASH and how it led him to develop the Fatty Liver Foundation.
Part II -
Advice for Patients with Recent Diagnosis of NASH with Fibrosis
Wayne Eskridge gives his advice to patients dealing with NASH, and NASH expert, Dr Scott Friedman, talks about what support clinicians should provide.
Part III -
After Diagnosis: What Happens Now?
Wayne Eskridge discusses what patients can do themselves to manage their disease, and Dr Scott Friedman talks about his outlook on future treatments for NASH.